ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,61
-0,33%
Bitcoin
60 262,25
-0,55%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Femasys Inc (FEMY)

  7. Femasys Inc (FEMY) Actualités

FEMY Femasys Inc

1,27
-0,05 (-3,79%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Femasys Inc FEMY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,05 -3,79% 1,27 00:33:37
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,33 1,27 1,33 1,27 1,32
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202414:30GLOBEFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members..
28/3/202421:05GLOBEFemasys Announces Financial Results for Year Ended December..
21/3/202414:00GLOBEFemasys Invites Investors to View Fireside Chat Today, March..
20/3/202413:15GLOBEFemasys Announces Positive Topline Data from Pivotal Trial..
13/3/202414:00GLOBEFemasys to Participate in Fireside Chat to Discuss the..
06/3/202415:09EDGAR2Form 8-K - Current report
06/3/202415:00GLOBEFemasys Completes the First In-Office Commercial Procedure..
28/2/202415:16EDGAR2Form 8-K - Current report
14/2/202403:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202403:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202414:47EDGAR2Form 8-K - Current report
02/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
08/12/202315:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/11/202323:17EDGAR2Form S-3 - Registration statement under Securities Act of..
29/11/202322:05EDGAR2Form 8-K - Current report
22/11/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:33EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/11/202323:30EDGAR2Form 8-K - Current report
15/11/202323:19EDGAR2Form 8-K - Current report
15/11/202314:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
02/11/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202314:01EDGAR2Form 8-K - Current report
03/10/202315:28EDGAR2Form 8-K - Current report
03/10/202315:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/9/202314:19EDGAR2Form 8-K - Current report
06/9/202323:00EDGAR2Form 8-K - Current report
10/8/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:05EDGAR2Form 8-K - Current report
07/8/202314:40EDGAR2Form DEF 14A - Other definitive proxy statements
03/8/202315:04EDGAR2Form 8-K - Current report
28/7/202323:15EDGAR2Form PRE 14A - Other preliminary proxy statements
27/7/202315:04EDGAR2Form 8-K - Current report
14/7/202322:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/7/202322:26EDGAR2Form S-1/A - General form for registration of securities..
04/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/7/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
FEMY
Femasys
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés